OREANDA-NEWS. Chimpharm JSC (Shymkent), whose securities are officially listed on Kazakhstan Stock Exchange (KASE), in an official letter informed KASE that the National Bank of Republic of Kazakhstan with Resolution of November 11, 2015 drew the company to administrative responsibility and imposed a penalty "for committing a violation stipulated in article 263 of Kazakhstan's Administrative Violations Code".